[go: up one dir, main page]

WO2025149807A1 - Système de dispositif médical implantable configuré pour la détermination d'une infection urinaire - Google Patents

Système de dispositif médical implantable configuré pour la détermination d'une infection urinaire

Info

Publication number
WO2025149807A1
WO2025149807A1 PCT/IB2024/062527 IB2024062527W WO2025149807A1 WO 2025149807 A1 WO2025149807 A1 WO 2025149807A1 IB 2024062527 W IB2024062527 W IB 2024062527W WO 2025149807 A1 WO2025149807 A1 WO 2025149807A1
Authority
WO
WIPO (PCT)
Prior art keywords
patient
uti
processing circuitry
particular period
bathroom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/IB2024/062527
Other languages
English (en)
Inventor
Wade M. Demmer
Michelle M. GALARNEAU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc filed Critical Medtronic Inc
Publication of WO2025149807A1 publication Critical patent/WO2025149807A1/fr
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
    • A61B5/1118—Determining activity level
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0031—Implanted circuitry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/01—Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/06—Devices, other than using radiation, for detecting or locating foreign bodies ; Determining position of diagnostic devices within or on the body of the patient
    • A61B5/065—Determining position of the probe employing exclusively positioning means located on or in the probe, e.g. using position sensors arranged on the probe
    • A61B5/067—Determining position of the probe employing exclusively positioning means located on or in the probe, e.g. using position sensors arranged on the probe using accelerometers or gyroscopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
    • A61B5/201—Assessing renal or kidney functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
    • A61B5/202—Assessing bladder functions, e.g. incontinence assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation

Definitions

  • the invention relates to medical device systems and, more particularly, medical device systems for determining a condition of a patient.
  • UTIs urinary tract infections
  • Complications of a UTI may include recurrent infections, especially in women who experience two or more UTIs in a six-month period or four or more UTIs within a year; permanent kidney damage from an acute or chronic kidney infection (pyelonephritis) due to an untreated UTI; increased risk in pregnant women of delivering low birth weight or premature infants; urethral narrowing (stricture) in men from recurrent urethritis, previously seen with gonococcal urethritis; and/or sepsis, a potentially life-threatening complication of an infection, especially if the infection works its way up the urinary tract to the kidneys.
  • nocturia which is characterized by the need to urinate while a patient is sleeping, thereby possibly interrupting a sleep state of the patient.
  • a medical device system may include an implantable medical device comprising a temperature sensor to sense body temperature of the patient and an accelerometer configured to sense activity of the patient.
  • the medical device system further includes processing circuitry configured to generate an initial determination that the patient has a UTI based on one or more of the sensed activity of the patient or the sensed body temperature of the patient.
  • processing circuitry In response to the initial determination that the patient has a UTI, processing circuitry causes a computing device to generate an output requesting the patient provide one or more patient inputs to respective questions regarding patient symptoms. For example, processing circuitry may automatically cause a computing device to generate an output requesting the patient provide one or more patient inputs to respective questions regarding patient symptoms. Processing circuitry is configured to receive the one or more patient inputs and determine/confirm the patient has the UTI based, at least in part, on the received patient inputs.
  • the techniques described herein may provide one or more advantages.
  • use of an implantable medical device comprising a temperature sensor and accelerometer for initial identification of possible UTI may enable continuous (e.g., periodically or on a triggered basis without requiring user intervention) surveillance of the patient for UTIs over a period months or years while the patient is outside of a clinic setting and without requiring significant patient compliance burden.
  • the techniques of causing a computing device to generate an output requesting the patient provide one or more patient inputs to respective questions regarding patient symptoms in response to the initial determination that the patient has a UTI and using the patient inputs to determine/confirm the patient has the UTI, may provide improved accuracy of determining UTI.
  • the system including an implantable medical device and techniques described herein may advantageously improve the speed of determining a UTI in a patient that may help enable treatment to be provided quicker to the patient, which improves patient health, reduces chances of serious illness caused by the UTI, which reduces hospitalizations and reduces healthcare costs. Further, such embodiments may enable monitoring and performance of novel computations in a continuous manner; this continuous operation can overcome limitations of a physician’s capability, for whom such continuous attention, monitoring, and computation would be infeasible.
  • this disclosure describes a system comprising: an implantable medical device (IMD) comprising: a temperature sensor configured to sense body temperature of a patient, and an accelerometer configured to sense activity of the patient; and processing circuitry configured to: generate an initial determination, based at least in part on one or more of the sensed activity of the patient and the sensed body temperature, the patient has a urinary tract infection (UTI), in response to the initial determination that the patient has the UTI, cause a computing device to generate an output requesting the patient provide one or more patient inputs to respective questions regarding patient symptoms, receive the one or more patient inputs, and determine the patient has the UTI based, at least in part, on the received patient inputs.
  • IMD implantable medical device
  • processing circuitry configured to: generate an initial determination, based at least in part on one or more of the sensed activity of the patient and the sensed body temperature, the patient has a urinary tract infection (UTI), in response to the initial determination that the patient has the UTI, cause a computing device to generate an output requesting
  • this disclosure describes a method for determining a patient has a urinary tract infection (UTI) comprising: sensing, by an implantable medical device (IMD), one or more of activity of the patient or body temperature of the patient; generating, by processing circuitry, an initial determination the patient has the UTI based at least in part on one or more of the sensed activity of the patient and the sensed body temperature; in response to the initial determination that the patient has the UTI, causing, by the processing circuitry, a computing device to generate an output requesting the patient provide one or more patient inputs to respective questions regarding patient symptoms; receiving, by the processing circuitry, the one or more patient inputs; and determining, by the processing circuitry, the patient has the UTI based, at least in part, on the received patient inputs.
  • IMD implantable medical device
  • this disclosure describes non-transitory computer-readable storage medium storing instructions, which when executed, cause processing circuitry to: sense, by an implantable medical device (IMD), one or more of activity of the patient or body temperature of the patient; generate, by processing circuitry, an initial determination the patient has the UTI based at least in part on one or more of the sensed activity of the patient and the sensed body temperature; in response to the initial determination that the patient has the UTI, cause, by the processing circuitry, a computing device to generate an output requesting the patient provide one or more patient inputs to respective questions regarding patient symptoms; receive, by the processing circuitry, the one or more patient inputs; and determine, by the processing circuitry, the patient has the UTI based, at least in part, on the received patient inputs.
  • IMD implantable medical device
  • FIG. 1 is a schematic diagram illustrating a system configured to monitor for the presence of a UTI in a patient, in accordance with some techniques of this disclosure.
  • FIG. 2 is a block diagram illustrating an example implantable medical device configured to monitor for the presence of a UTI in a patient, in accordance with some techniques of this disclosure.
  • FIG. 3 is a block diagram illustrating an example computing device configured to monitor for the presence of a UTI in a patient, in accordance with some techniques of this disclosure.
  • IMD 10 may further determine a UTI threshold is satisfied based on one or more other metrics, such as HR or HRV, measured by IMD 10 satisfying a corresponding other metrics UTI threshold.
  • processing circuitry of IMD 10 is configured to cause computing device 12 to generate an output requesting patient provide or more patient inputs to respective questions regarding patient symptoms.
  • IMD 10 may be configured to send a notification or other message to computing device 12 in response to satisfaction of the UTI threshold to cause computing device 12 to generate an output requesting patient provide or more patient inputs to respective questions regarding patient symptoms.
  • processing circuitry 50 may include multiple components, such as any combination of one or more microprocessors, one or more controllers, one or more DSPs, one or more ASICs, or one or more FPGAs, as well as other discrete or integrated logic circuitry.
  • the functions attributed to processing circuitry 50 herein may be embodied as software, firmware, hardware or any combination thereof.
  • processing circuitry 50 may determine an amount of time patient 4 spends inactive, e.g., sleeping.
  • the one or more temperature sensors 62B may be configured to generate signals that indicate body temperature of patient 4.
  • processing circuitry 50 may quantify an amount of change in HRV over a period of time, such as a decrease in HRV over a period of time.
  • processing circuitry 50 may be configured to analyze the accelerometer data in order to identify activity patterns likely due to a bladder-voiding event, e.g., rather than a different nighttime activity.
  • processing circuitry 50 may use accelerometer data to determine a posture of patient 4, with certain upright postures, or transitions to and from upright postures, indicating that the patient has awoken and returned to sleep.
  • processing circuitry 50 may identify a number of steps during the first or second increased activity level, and determine whether the number of steps is indicative of (e.g., falls within a threshold window of) the patient walking between the bedroom and the bathroom.
  • processing circuitry 50 may be configured to receive time duration data, e.g., from a clock or timer included as part of processing circuitry 50, collected during one or more of the detected activity levels, and determine whether the time duration is indicative of, e.g., falls within a threshold window of, the patient walking to the bathroom, voiding a bladder, or returning to the bedroom, respectively.
  • processing circuitry 50 may be configured to determine, based on the received activity-level data, whether a cumulative activity level amount (e.g., the detected activity level integrated over the time during which the level is detected) is indicative of the patient walking to and/or from the bathroom.
  • a cumulative activity level amount e.g., the detected activity level integrated over the time during which the level is detected
  • processing circuitry 50 may identify an out of bed (OOB) event based on the activity data, e.g., level, steps, or duration, falling within threshold window that is determined statistically based on previous OOB events of the patient or of a population of patients.
  • OOB out of bed
  • processing circuitry 50 may identify an OOB event based on the activity data and HR data, such as HR data showing an increased HR over a period of time that may indicate patient transitioned from a sleeping state to an awake state.
  • processing circuitry 50 may begin monitoring activity data in response to determining patient transitioned from a sleeping state to an awake state.
  • processing circuitry 50 may compare the amount of nighttime bathroom trips for the particular period of time to the baseline amount of nighttime bathroom trips to determine a difference between the amount of nighttime bathroom trips for the particular period of time to the baseline amount of nighttime bathroom trips. In some examples, processing circuitry 50 may determine whether the difference between the amount of nighttime bathroom trips for the particular period of time to the baseline amount of nighttime bathroom trips satisfies a UTI increased bathroom trip threshold for the particular period of time. In some examples, a UTI increased bathroom trip threshold may be one or more increased trips to the bathroom per night. In some examples, a UTI increased bathroom trip threshold may be two or more trips to the bathroom per night.
  • processing circuitry 50 may determine that the determined difference between the amount of nighttime bathroom trips for the particular period of time to the baseline amount of nighttime bathroom trips satisfies the UTI increased bathroom trip threshold.
  • IMD 10 may determine a difference between the amount of nighttime bathroom trips for the particular period of time to the baseline amount of nighttime bathroom trips satisfies a UTI increased bathroom trip threshold based on applying the difference to a machine learning model and the machine learning model determining the difference satisfies the UTI increased bathroom trip threshold.
  • processing circuitry 50 may determine whether patient 4 has a fever for the particular period of time based on the sensed body temperature sensed by the temperature sensor 62B. In some examples, processing circuitry 50 may determine whether the sensed body temperature during the particular period of time satisfies a UTI fever threshold and may determine patient 4 has a fever for the particular period of time based on the sensed body temperature during the particular period of time satisfying a UTI fever threshold. In some examples, the particular period of time may correspond to the particular period of time processing circuitry 50 determines that the determined difference between the amount of nighttime bathroom trips for the particular period of time to the baseline amount of nighttime bathroom trips satisfies the UTI increased bathroom trip threshold.
  • processing circuitry 50 may initially determine patient 4 has a UTI.
  • processing circuitry 50 may cause computing device 12 to generate an output requesting patient 4 provide one or more patient inputs to respective questions regarding patient symptoms, such as by sending a notification to computing device 12 to generate an output requesting patient provide one or more patient inputs to respective questions regarding patient symptoms.
  • the output requesting patient provide one or more patient inputs may be a push notification.
  • the respective questions may correspond to values of sensed body temperature and/or the sensed patient activity.
  • patient questions may include follow-up questions regarding increased levels of patient activity and/or body temperature levels that indicate a fever.
  • the follow-up questions may correspond to other UTI symptoms, such as fatigue and/or tremors; agitation and/or restlessness; lower back pain; painful urination (e.g., a “burning” sensation); and/or presyncope and/or syncope (e.g., sudden loss of consciousness and/or falls).
  • other UTI symptoms such as fatigue and/or tremors; agitation and/or restlessness; lower back pain; painful urination (e.g., a “burning” sensation); and/or presyncope and/or syncope (e.g., sudden loss of consciousness and/or falls).
  • processing circuitry 50 may automatically cause a notification to computing device 12 to generate an output requesting patient 4 provide one or more patient inputs to respective questions regarding patient symptoms, such as by sending a notification to computing device 12 to generate an output requesting patient 4 provide one or more patient inputs to respective questions regarding patient symptoms.
  • processing circuitry 50 initially determining that the patient has the UTI based on body temperature and patient activity and automatically causing computing device 12 to generate an output requesting patient 4 provide one or more patient inputs to respective questions regarding patient symptoms to determine whether to determine/confirm the patient 4 has the UTI, provides improved determinations of a UTI while also making the determinations more efficient and faster than a patient 4 waiting to interact with a care provider. This improvement in accuracy and time to determine patient 4 has a UTI enables treatment to be provided sooner to the patient, which improves patient 4 health while reducing chances of hospitalizations, which reduces healthcare costs.
  • processing circuitry 50 may receive the one or more patient 4 inputs and determine whether to determine/confirm the patient has the UTI based, at least in part, on the received patient inputs. For example, processing circuitry 50 may receive user inputs that indicate the patient 4 has painful urination and was having to use the bathroom at a much higher rate than normal and determine/confirm patient symptoms indicate a UTI. In some examples, in response to a determination that the patient has the UTI, processing circuitry 50 may send one or more of an indication to see a care provider, an indication to go to an emergency room, and/or an indication to proceed with a treatment, such as taking a particular medication.
  • processing circuitry 50 may additionally or alternatively send a confirmation request to patient 4 to confirm, such as by patient input, that the patient computing device received an indication such as an indication that the patient has a UTI, to see a care provider, an indication to go to an emergency room, and/or an indication to proceed with a treatment, such as taking a particular medication.
  • FIG. 3 is a block diagram illustrating an example computing device 12 in accordance with techniques of this disclosure.
  • computing device 12 may be a patient computing device, such as a patient smart phone, tablet, or personal computer.
  • Computing device 12 includes a communication element 230, memory 240, processing circuitry 260, power source 280, communication circuitry 300, a user interface 310, and in some examples, one or more integrated sensor(s) 320.
  • communication element 230 is depicted in FIG. 3 as an antenna, communication element 230 may include any physical component configured to facilitate communication with, e.g., to receive sensor data from IMD 10 (FIG. 1).
  • Memory 240 of computing device 12 may include any volatile or non-volatile media, such as any one or more of a random access memory (RAM), read-only memory (ROM), nonvolatile RAM (NVRAM), electronically-erasable programmable ROM (EEPROM), flash memory, and the like, all of which may constitute “non-transitory storage media.”
  • Memory 240 is configured to store sensor data as well as instructions that, when executed by processing circuitry 260, cause processing circuitry 260 to process the stored sensor data to identify sensor data indicative of one or more symptoms of a UTI, and based on the analysis of the sensor data, determine whether a UTI is likely present in a patient, e.g., determine a probability that a patient has a UTI.
  • Memory 240 may also store data generated by IMD 10 (FIG. 1) and/or processing circuitry 260.
  • Processing circuitry 260 may include any one or more of a microprocessor, a controller, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA), discrete logic circuitry, or the like. Processing circuitry 260 is configured to execute one or more sets of instructions according to the techniques of this disclosure. For example, processing circuitry 260 may be configured to receive, via communication element 230 and communication circuitry 300 from IMD 10 (FIG. 1), sensor data indicative of activity of the patient and body temperature of the patient.
  • IMD 10 FIG. 1
  • Processing circuitry 260 may be coupled to power source 280.
  • Power source 260 may include a battery and/or wired power connection.
  • power source 280 may take the form of a small, rechargeable or non-rechargeable battery, or an inductive power interface that transcutaneously receives inductively coupled energy.
  • power source 280 similarly may include an inductive power interface for transcutaneous transfer of recharge power.
  • User interface 310 of computing device 12 may include one or more user input devices and one or more user output devices, e.g., a touch screen display or other display, a pointing device, a keyboard, or the like.
  • processing circuitry 260 may present a variety of information to a user, including respective questions regarding patient symptoms, via user interface 310.
  • Communication circuitry 300 supports wireless communication with IMD 10 that generates signals indicative of physiological parameters patient 4 and transmits the signals and/or physiological parameters determined based on the signals to computing device 12.
  • Communication circuitry 300 is configured to support wireless communication for computing device 12 to receive a notification from the IMD 10 to generate an output requesting patient 4 to provide one or more patient inputs to respective questions regarding patient symptoms.
  • computing device 12 may output the respective questions via user interface 310 and/or a speaker.
  • computing device 12 may receive user inputs to the respective questions via user interface 310 and/or a microphone.
  • Computing device 12 may transmit the one or more patient 4 inputs in response to the respective questions to IMD 10 using communication circuitry 300.
  • Such communication may be via any wireless communication protocol, such as known medical device telemetry protocols, or the BluetoothTM protocol.
  • computing device 12 includes one or more sensor(s) 320.
  • Sensor(s) 320 may include any one or more of the example sensors discussed herein with respect to sensors 62 of IMD 10 (FIGS. 1-2).
  • sensor(s) 320 may one or more of a microphone or a camera to capture audio and/or image data of patient 14.
  • FIG. 4A is a conceptual drawing illustrating an IMD 10A, which may be an example configuration of IMD 10 of FIGS. 1-2 as an ICM.
  • IMD 10A may be embodied as a monitoring device having housing 15, proximal electrode 16A and distal electrode 16B, and sensor(s) 62.
  • the sensor(s) 62 may be positioned at various locations on IMD 10A.
  • Sensor(s) 62 may include one or more accelerometers 62A and one or more temperature sensors 62B.
  • Housing 15 may further comprise first major surface 14, second major surface 18, proximal end 20, and distal end 22. Housing 15 encloses electronic circuitry located inside the IMD 10A and protects the circuitry contained therein from body fluids. Electrical feedthroughs provide electrical connection of electrodes 16A and 16B.
  • IMD 10A is defined by a length L, a width W and thickness or depth D and is in the form of an elongated rectangular prism wherein the length L is much larger than the width W, which in turn is larger than the depth D.
  • the geometry of the IMD 10A - in particular a width W greater than the depth D - is selected to allow IMD 10A to be inserted under the skin of the patient using a minimally invasive procedure and to remain in the desired orientation during and after insertion.
  • the device shown in FIG. 4A includes radial asymmetries (notably, the rectangular shape) along the longitudinal axis that maintains the device in the proper orientation following insertion.
  • the spacing between proximal electrode 64 and distal electrode 66 may range from 30 millimeters (mm) to 55mm, 35mm to 55mm, and from 40mm to 55mm and may be any range or individual spacing from 25mm to 60mm.
  • IMD 10A may have a length E that ranges from 30mm to about 70mm.
  • the length L may range from 5mm to 60mm, 15mm to 50mm, 40mm to 60mm, 45mm to 60mm and may be any length or range of lengths between about 5mm and about 80mm.
  • the width W of major surface 14 may range from 5mm to 15mm, 3mm to 10mm, and may be any single or range of widths between 3mm and 15mm.
  • the thickness of depth D of IMD 10A may range from 2mm to 9mm. In other examples, the depth D of IMD 10A may range from 2mm to 5mm, may range from 5mm to 15mm, and may be any single or range of depths from 2mm to 15mm.
  • IMD 10A according to an example of the present disclosure has a geometry and size designed for ease of implant and patient comfort. Examples of IMD 10A described in this disclosure may have a volume of three cubic centimeters (cm) or less, 1.5 cubic cm or less or any volume between three and 1.5 cubic cm.
  • the first major surface 14 faces outward, toward the skin of the patient while the second major surface 18 is located opposite the first major surface 14.
  • proximal end 20 and distal end 22 are rounded to reduce discomfort and irritation to surrounding tissue once inserted under the skin of the patient.
  • IMD 10A including instrument and method for inserting IMD 10 is described, for example, in U.S. Patent Publication No. 2014/0276928, incorporated herein by reference in its entirety.
  • Proximal electrode 16A and distal electrode 16B are used to sense cardiac signals, e.g.
  • EGM signals intra-thoracically or extra-thoracically, which may be sub- muscularly or subcutaneously.
  • EGM signals may be stored in a memory of IMD 10A, and data may be transmitted via integrated antenna 30A to another medical device, which may be another implantable device or an external device, such as external device 12.
  • electrodes 16A and 16B may additionally or alternatively be used for sensing any bio-potential signal of interest, which may be, for example, an ECG, EGM, EEG, EMG, or a nerve signal, from any implanted location.
  • proximal electrode 16A is in close proximity to the proximal end 20 and distal electrode 16B is in close proximity to distal end 22.
  • distal electrode 16B is not limited to a flattened, outward facing surface, but may extend from first major surface 14 around rounded edges 24 and/or end surface 25 and onto the second major surface 18 so that the electrode 16B has a three-dimensional curved configuration.
  • electrode 16B is an uninsulated portion of a metallic, e.g., titanium, part of housing 15.
  • proximal electrode 16A is located on first major surface 14 and is substantially flat, and outward facing.
  • proximal electrode 16A may utilize the three dimensional curved configuration of distal electrode 16B, providing a three dimensional proximal electrode (not shown in this example).
  • distal electrode 16B may utilize a substantially flat, outward facing electrode located on first major surface 14 similar to that shown with respect to proximal electrode 16A.
  • proximal electrode 16A and distal electrode 16B are located on both first major surface 14 and second major surface 18.
  • proximal electrode 16A and distal electrode 16B are located on both first major surface 14 and second major surface 18.
  • both proximal electrode 16A and distal electrode 16B are located on one of the first major surface 14 or the second major surface 18 (e.g., proximal electrode 16A located on first major surface 14 while distal electrode 16B is located on second major surface 18).
  • IMD 10A may include electrodes on both major surface 14 and 18 at or near the proximal and distal ends of the device, such that a total of four electrodes are included on IMD 10A.
  • Electrodes 16A and 16B may be formed of a plurality of different types of biocompatible conductive material, e.g., stainless steel, titanium, platinum, iridium, or alloys thereof, and may utilize one or more coatings such as titanium nitride or fractal titanium nitride.
  • proximal end 20 includes a header assembly 28 that includes one or more of proximal electrode 16A, integrated antenna 30A, antimigration projections 32, and/or suture hole 34.
  • Integrated antenna 30A is located on the same major surface (i.e., first major surface 14) as proximal electrode 16A and is also included as part of header assembly 28.
  • Integrated antenna 30A allows IMD 10A to transmit and/or receive data.
  • integrated antenna 30A may be formed on the opposite major surface as proximal electrode 16A, or may be incorporated within the housing 15 of IMD 10A. In the example shown in FIG.
  • anti-migration projections 32 are located adjacent to integrated antenna 30A and protrude away from first major surface 14 to prevent longitudinal movement of the device.
  • anti-migration projections 32 include a plurality (e.g., nine) small bumps or protrusions extending away from first major surface 14.
  • header assembly 28 includes suture hole 34, which provides another means of securing IMD 10A to the patient to prevent movement following insertion.
  • suture hole 34 is located adjacent to proximal electrode 16A.
  • header assembly 28 is a molded header assembly made from a polymeric or plastic material, which may be integrated or separable from the main portion of IMD 10A.
  • FIG. 4B is a perspective drawing illustrating another IMD 10B, which may be another example configuration of IMD 10 from FIGS. 1-2.
  • IMD 10B of FIG. 4B may be configured substantially similarly to IMD lOA of FIG. 4A, with differences between them discussed herein.
  • IMD 10B may include a leadless, subcutaneously-implantable monitoring device, e.g. an ICM.
  • IMD 10B includes housing having a base 40 and an insulative cover 42.
  • IMD 10B includes sensor(s) 62 that may be positioned at various locations on IMD 10B.
  • Sensor(s) 62 may include one or more accelerometers 62A and one or more temperature sensors 62B.
  • Proximal electrode 16C and distal electrode 16D may be formed or placed on an outer surface of cover 42.
  • Various circuitries and components of IMD 10B e.g., described below with respect to FIG. 3, may be formed or placed on an inner surface of cover 42, or within base 40.
  • a battery or other power source of IMD 10B may be included within base 40.
  • antenna 30B is formed or placed on the outer surface of cover 42, but may be formed or placed on the inner surface in some examples.
  • insulative cover 42 may be positioned over an open base 40 such that base 40 and cover 42 enclose the circuitries and other components and protect them from fluids such as body fluids.
  • Circuitries and components may be formed on the inner side of insulative cover 42, such as by using flip-chip technology.
  • Insulative cover 42 may be flipped onto a base 40. When flipped and placed onto base 40, the components of IMD 10B formed on the inner side of insulative cover 42 may be positioned in a gap 44 defined by base 40. Electrodes 16C and 16D and antenna 30B may be electrically connected to circuitry formed on the inner side of insulative cover 42 through one or more vias (not shown) formed through insulative cover 42.
  • Insulative cover 42 may be formed of sapphire (i.e., corundum), glass, parylene, and/or any other suitable insulating material.
  • Base 40 may be formed from titanium or any other suitable material (e.g., a biocompatible material). Electrodes 16C and 16D may be formed from any of stainless steel, titanium, platinum, iridium, or alloys thereof. In addition, electrodes 16C and 16D may be coated with a material such as titanium nitride or fractal titanium nitride, although other suitable materials and coatings for such electrodes may be used.
  • a material such as titanium nitride or fractal titanium nitride, although other suitable materials and coatings for such electrodes may be used.
  • the housing of IMD 10B defines a length L, a width W and thickness or depth D and is in the form of an elongated rectangular prism wherein the length L is much larger than the width W, which in turn is larger than the depth D, similar to IMD 10A of FIG. 4B.
  • the spacing between proximal electrode 64 and distal electrode 66 may range from 30mm to 50mm, from 35mm to 45mm, or be approximately 40mm.
  • IMD 10B may have a length L that ranges from 30mm to about 70mm. In other examples, the length L may range from 5mm to 60mm, 40mm to 60mm, 45mm to 55mm, or be approximately 45mm.
  • the width W may range from 3mm to 15mm, such as approximately 8mm.
  • the thickness of depth D of IMD 10B may range from 2mm to 15mm, from 3 to 5mm, or be approximately 4mm.
  • IMD 10B may have a volume of three cubic centimeters (cm) or less, or 1.5 cubic cm or less, such as approximately 1.4 cubic cm.
  • proximal end 46 and distal end 48 are rounded to reduce discomfort and irritation to surrounding tissue once inserted.
  • FIG. 5 is a block diagram illustrating an example system that includes an access point 90, a network 92, external computing devices, such as a server 94, and one or more computing devices 100A-100N (collectively, “computing devices 100”), which may be coupled to IMD 10 and external device 12 via network 92, in accordance with one or more techniques described herein.
  • the external device 12 in FIG. 5 corresponds to the computing device 12 ins FIGS. 1 and 3.
  • IMD 10 may use communication circuitry 54 to communicate with external device 12 via a first wireless connection, and to communicate with an access point 90 via a second wireless connection.
  • access point 90, external device 12, server 94, and computing devices 100 are interconnected and may communicate with each other through network 92.
  • Access point 90 may include a device that connects to network 92 via any of a variety of connections, such as telephone dial-up, digital subscriber line (DSL), or cable modem connections. In other examples, access point 90 may be coupled to network 92 through different forms of connections, including wired or wireless connections. In some examples, access point 90 may be a user device, such as a tablet or smartphone, that may be co-located with the patient.
  • DSL digital subscriber line
  • access point 90 may be a user device, such as a tablet or smartphone, that may be co-located with the patient.
  • IMD 10 may be configured to transmit data, such as temperature data, accelerometer signals, indications of whether the patient has an initial determination of having a UTI, signals to cause a computing device to generate an output requesting the patient provide one or more patient inputs to respective questions regarding patient symptoms, indications of whether the patient is determined to have the UTI, and/or indications of treatment instructions to access point 90. Access point 90 may then communicate the retrieved data to server 94 via network 92.
  • server 94 may be configured to provide a secure storage site for data that has been collected from IMD 10 and/or external device 12.
  • server 94 may assemble data in web pages or other documents for viewing by trained professionals, such as clinicians, via computing devices 100.
  • server 94 may communicate with computing device 100 via network 92.
  • server 94 may communicate an analysis of data, such as determination of whether body temperature of the patient 14 and/or sensed activity of the patient 14 indicates an initial determination that patient has a UTI and/or determination/confirmation the patient has the UTI based, at least in part, on received patient inputs to questions regarding patient symptoms, to computing device 100, external device 12, or any other computing device via network 92.
  • server 94 includes a storage device 96, e.g., to store data retrieved from IMD 10, and processing circuitry 98.
  • computing devices 100 may similarly include a storage device and processing circuitry.
  • Processing circuitry 98 may include one or more processors that are configured to implement functionality and/or process instructions for execution within server 94.
  • processing circuitry 98 may be capable of processing instructions stored in memory 96.
  • Processing circuitry 98 may include or be coupled to communication circuitry that may include any suitable hardware, firmware, software or any combination thereof for communicating with another device.
  • a description of processing circuitry 98 outputting a signal may include processing circuitry 98 causing communication circuitry of server 94 to output the signal.
  • Processing circuitry 98 may include, for example, microprocessors, DSPs, ASICs, FPGAs, or equivalent discrete or integrated logic circuitry, or a combination of any of the foregoing devices or circuitry. Accordingly, processing circuitry 98 may include any suitable structure, whether in hardware, software, firmware, or any combination thereof, to perform the functions ascribed herein to processing circuitry 98.
  • Processing circuitry 98 of server 94 and/or the processing circuity of computing devices 100 may implement any of the techniques described herein to determine the onset or presence of a UTI in a patient based at least in part on data collected by an accelerometer 62A and a temperature sensor 62B of an implantable medical device system, and responsively prompting the patient with questions regarding patient symptoms to determine/confirm the presence of the UTI in the patient based at least in part on patient inputs received in response to the respective questions.
  • Storage device 96 may include a computer-readable storage medium or computer-readable storage device.
  • memory 96 includes one or more of a short-term memory or a long-term memory.
  • Storage device 96 may include, for example, RAM, DRAM, SRAM, magnetic discs, optical discs, flash memories, or forms of EPROM or EEPROM.
  • storage device 96 is used to store data indicative of instructions for execution by processing circuitry 98.
  • the techniques for determining the onset or presence of a UTI in a patient based at least in part on data collected by an accelerometer 62A and a temperature sensor 62B of an implantable medical device system, and responsively prompting the patient with questions regarding patient symptoms to determine/confirm the presence of the UTI in the patient based at least in part on patient inputs received in response to the respective questions are described herein primarily as being performed by processing circuitry 50 of IMD 10, such techniques may be performed, in whole or part, by processing circuitry of any one or more devices of system 2, such as processing circuitry 80 of external device 12, processing circuitry 98 of server 94, or processing circuitry of one or more computing devices 100.
  • FIG. 6 is a flow diagram illustrating an example method for determining the onset or presence of a UTI in a patient based at least in part on data collected by an accelerometer 62A and a temperature sensor 62B of an implantable medical device system, and responsively prompting the patient with questions regarding patient symptoms to determine/confirm the presence of the UTI in the patient based at least in part on patient inputs received in response to the respective questions, in accordance with techniques of this disclosure.
  • processing circuitry 50 may generate, based at least on sensed activity of patient 4 or body temperature of patient 4, an initial determination that the patient 4 has a UTI (600).
  • IMD 10 includes sensor(s) 62, such as a temperature sensor 62B configured to sense body temperature of a patient and an accelerometer 62A configured to sense activity of the patient 4.
  • processing circuitry 50 may generate the initial determination that the patient 4 has a UTI based on the sensed activity of patient 4 and the body temperature of patient 4.
  • processing circuitry 50 may determine, based at least in part on the sensed activity of the patient, a baseline amount of nighttime bathroom trips for the patient and may determine, based at least in part on the sensed activity of the patient during a particular period of time, an amount of nighttime bathroom trips for the patient for the particular period of time, and may determine a difference between the amount of nighttime bathroom trips for the particular period of time and the baseline amount of nighttime bathroom trips. In some examples, processing circuitry 50 may determine whether the determined difference between the amount of nighttime bathroom trips for the particular period of time and the baseline amount of nighttime bathroom trips satisfies a UTI increased bathroom trip threshold for the particular period of time.
  • processing circuitry 50 may determine, based on sensed body temperature during the particular period of time, whether patient has a fever during the particular period of time. In some examples, processing circuitry 50 may determine whether the sensed body temperature during the particular period of time satisfies a UTI fever threshold.
  • processing circuitry 50 may generate the initial determination that patient has the UTI.
  • processing circuitry 50 may generate an initial determination that patient has the UTI.
  • processing circuitry 50 may cause computing device 12 to generate an output requesting the patient 4 provide one or more patient inputs to respective questions regarding patient symptoms (602).
  • processing circuitry 50 may automatically cause computing device 12 to generate an output requesting the patient 4 provide one or more patient inputs to respective questions regarding patient symptoms in response to the generation of the initial determination that the patient has a UTI.
  • the respective questions may correspond or relate to one or more of the sensed activity of the patient or the sensed body temperature.
  • Processing circuitry 50 may receive one or more patient inputs (604).
  • Processing circuitry 50 may determine/confirm the patient has the UTI based, at least in part, on the received patient inputs (606). Processing circuitry 50 may cause computing device 12 to generate an output indicating whether the patient is determined/confirmed to have the UTI and/or treatment instructions (608). For example, in response to a determination the patient has the UTI based, at least in part, on the received patient inputs, processing circuitry 50 cause computing device 12 to generate an output including one or more of: an urgent notification that the patient has the UTI, a notification to patient 4 to seek medical attention; and/or an indication to patient to perform a treatment, such as instructions on medication for patient 4 to take. In some examples, the outputs may be sent to other computing devices, such as computing devices of caregivers. For example, computing device 12 may generate an of an urgent notification that the patient has the UTI to be sent to a computing device of a caregiver, such as a nurse, clinician, family member, etc.
  • processing circuitry 50 may cause computing device 12 to generate an output and await a response, such as a response input by patient 4, from computing device 12 over a period of time, such as a response threshold period of time. In some examples, if processing circuitry 50 does not determine a response has been received within the response threshold period of time or within a threshold amount of outputs (e.g., such as, but not limited to, up to six notifications having been sent to patient over a period of time, such as up to 12 hours, and no response from the computing device of the patient has been received) generated by computing device 12, processing circuitry 50 may cause an output be sent to a computing device of an alert caregiver.
  • a response threshold period of time e.g., such as, but not limited to, up to six notifications having been sent to patient over a period of time, such as up to 12 hours, and no response from the computing device of the patient has been received
  • a system includes an implantable medical device (IMD) includes a temperature sensor configured to sense body temperature of a patient, and an accelerometer configured to sense activity of the patient; and processing circuitry configured to: generate an initial determination, based at least in part on one or more of the sensed activity of the patient and the sensed body temperature, the patient has a urinary tract infection (UTI), in response to the initial determination that the patient has the UTI, cause a computing device to generate an output requesting the patient provide one or more patient inputs to respective questions regarding patient symptoms, receive the one or more patient inputs, and determine the patient has the UTI based, at least in part, on the received patient inputs.
  • IMD implantable medical device
  • processing circuitry configured to: generate an initial determination, based at least in part on one or more of the sensed activity of the patient and the sensed body temperature, the patient has a urinary tract infection (UTI), in response to the initial determination that the patient has the UTI, cause a computing device to generate an output requesting the patient provide one or more patient input
  • Example 2 The system of example 1, wherein the processing circuitry is configured to generate the initial determination that the patient has the UTI based at least in part on the sensed activity of the patient and the sensed body temperature.
  • Example 3 The system of any of examples 1-2, wherein to generate the initial determination that the patient has the UTI based at least in part on the sensed activity of the patient the processing circuitry is configured to: determine, based at least in part on the sensed activity of the patient, a baseline amount of nighttime bathroom trips for the patient; determine, based at least in part on the sensed activity of the patient during a particular period of time, an amount of nighttime bathroom trips for the patient for the particular period of time; determine a difference between the amount of nighttime bathroom trips for the particular period of time and the baseline amount of nighttime bathroom trips; and determine whether the determined difference between the amount of nighttime bathroom trips for the particular period of time and the baseline amount of nighttime bathroom trips satisfies a UTI increased bathroom trip threshold for the particular period of time.
  • Example 4 The system of example 3, wherein to generate the initial determination that the patient has the UTI based at least in part on the sensed body temperature of the patient the processing circuitry is configured to: determine, based on sensed body temperature during the particular period of time, whether the patient has a fever during the particular period of time.
  • Example 5 The system of example 4, wherein to generate the initial determination that the patient has the UTI based at least in part on the sensed activity of the patient and the sensed body temperature of the patient the processing circuitry is configured to: in response to a determination that the determined difference between the amount of nighttime bathroom trips for the particular period of time and the baseline amount of nighttime bathroom trips satisfies the UTI increased bathroom trip threshold for the particular period of time and the determination that the patient has a fever for the particular period of time, generating the initial determination that patient has the UTI.
  • Example 6 The system of example 3, wherein to generate the initial determination that the patient has the UTI based at least in part on the sensed body temperature of the patient the processing circuitry is configured to: determine whether the sensed body temperature during the particular period of time satisfies a UTI fever threshold.
  • Example 7 The system of any of examples 1-6, wherein to generate the initial determination that the patient has the UTI based at least in part on the sensed activity of the patient and the sensed body temperature of the patient the processing circuitry is configured to: in response to a determination that the determined difference between the amount of nighttime bathroom trips for the particular period of time and the baseline amount of nighttime bathroom trips satisfies the UTI increased bathroom trip threshold for the particular period of time and the determination that the sensed body temperature during the particular period of time satisfies the UTI fever threshold, generating the initial determination that patient has the UTI.
  • Example 8 The system of any of examples 1-7, wherein the respective questions correspond to one or more of the sensed activity of the patient or the sensed body temperature.
  • Example 9 The system of any of examples 1-8, wherein the processing circuitry is further configured to automatically cause the computing device to generate the output requesting the patient provide one or more patient inputs to respective questions regarding patient symptoms in response to the initial determination that the patient has the UTI.
  • Example 10 The system of any of examples 1-9, wherein the processing circuitry is further configured to, in response to a determination the patient has the UTI based, at least in part, on the received patient inputs, cause the computing device to generate an output including one or more of: an indication that the patient has the UTI; a prompt to the patient to seek medical attention; a confirmation request to the patient to confirm receipt; or an indication to patient to perform a treatment.
  • Example 11 The system of example 10, wherein the indication to patient to perform a treatment includes instructions on medication for patient to take.
  • Example 12 The system of any of examples 1-11, wherein the processing circuitry is located in the implantable medical device.
  • Example 13 The system of any of examples 1-12, wherein the implantable medical device is an insertable cardiac monitor (ICM) further includes a housing configured for subcutaneous implantation within a patient; and a plurality of electrodes on the housing, wherein the ICM is configured to sense a cardiac electrogram (EGM) of the patient via the plurality of electrodes; a power source operatively coupled to the processing circuitry; a memory operatively coupled to the processing circuitry; and wherein the plurality of electrodes are operatively coupled to the processing circuitry, wherein the housing is a hermetically- sealed housing, wherein at least the power source, memory, and processing circuitry are within the hermetically- sealed housing, and wherein the housing has a length, a width, and a depth, wherein the length is greater than the width and the width is greater than the depth, wherein the length is within a range from 5 millimeters (mm) to 60 mm, wherein the width is within a range from 5 mm to 15 mm, and where
  • Example 14 A method for determining a patient has a urinary tract infection (UTI) includes sensing, by an implantable medical device (IMD), one or more of activity of the patient or body temperature of the patient; generating, by processing circuitry, an initial determination the patient has the UTI based at least in part on one or more of the sensed activity of the patient and the sensed body temperature; in response to the initial determination that the patient has the UTI, causing, by the processing circuitry, a computing device to generate an output requesting the patient provide one or more patient inputs to respective questions regarding patient symptoms; receiving, by the processing circuitry, the one or more patient inputs; and determining, by the processing circuitry, the patient has the UTI based, at least in part, on the received patient inputs.
  • IMD implantable medical device
  • Example 15 The method of example 14, wherein the method is configured to generate the initial determination that the patient has the UTI based at least in part on sensed activity of the patient and sensed body temperature.
  • Example 16 The method of any of examples 14-15, wherein to generate the initial determination that the patient has the UTI based at least in part on the sensed activity of the patient the method further comprises: determining, based at least in part on sensed activity of the patient, a baseline amount of nighttime bathroom trips for the patient; determining, based at least in part on sensed activity of the patient during a particular period of time, an amount of nighttime bathroom trips for the patient for the particular period of time; determining a difference between the amount of nighttime bathroom trips for the particular period of time and the baseline amount of nighttime bathroom trips; and determining whether the determined difference between the amount of nighttime bathroom trips for the particular period of time and the baseline amount of nighttime bathroom trips satisfies a UTI increased bathroom trip threshold for the particular period of time.
  • Example 19 The method of example 16, wherein to generate the initial determination that the patient has the UTI based at least in part on the sensed body temperature of the patient the method further comprises: determining whether the sensed body temperature during the particular period of time satisfies a UTI fever threshold.
  • Example 20 The method of example 19, to generate the initial determination that the patient has the UTI based at least in part on the sensed activity of the patient and the sensed body temperature of the patient the method further comprises: in response to a determination that the determined difference between the amount of nighttime bathroom trips for the particular period of time and the baseline amount of nighttime bathroom trips satisfies the UTI increased bathroom trip threshold for the particular period of time and the determination that the sensed body temperature during the particular period of time satisfies the UTI fever threshold, generating the initial determination that patient has the UTI.
  • Example 24 The method of example 23, wherein the indication to patient to perform a treatment includes instructions on medication for patient to take.
  • Example 25 A non-transitory computer-readable storage medium storing instructions, which when executed, cause processing circuitry to execute any of the methods recited in examples 14-24.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Urology & Nephrology (AREA)
  • Human Computer Interaction (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Dentistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

Un système donné à titre d'exemple comprend un dispositif médical implantable (IMD) comprenant un capteur de température configuré pour détecter la température corporelle d'un patient, et un accéléromètre configuré pour détecter l'activité du patient ; et un circuit de traitement configuré pour : générer une détermination initiale, sur la base, au moins en partie, d'une ou de plusieurs de l'activité détectée du patient et de la température corporelle détectée, le patient présentant une infection urinaire (UTI), en réponse à la détermination initiale que le patient présente l'UTI, amener un dispositif informatique à générer une sortie demandant au patient de fournir une ou plusieurs entrées de patient à des questions respectives concernant des symptômes de patient, recevoir la ou les entrées de patient, et déterminer que le patient présente l'UTI sur la base, au moins en partie, des entrées de patient reçues.
PCT/IB2024/062527 2024-01-10 2024-12-11 Système de dispositif médical implantable configuré pour la détermination d'une infection urinaire Pending WO2025149807A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202463619534P 2024-01-10 2024-01-10
US63/619,534 2024-01-10

Publications (1)

Publication Number Publication Date
WO2025149807A1 true WO2025149807A1 (fr) 2025-07-17

Family

ID=94227781

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2024/062527 Pending WO2025149807A1 (fr) 2024-01-10 2024-12-11 Système de dispositif médical implantable configuré pour la détermination d'une infection urinaire

Country Status (1)

Country Link
WO (1) WO2025149807A1 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140276928A1 (en) 2013-03-15 2014-09-18 Medtronic, Inc. Subcutaneous delivery tool
US20160015758A1 (en) * 2014-07-21 2016-01-21 Medstar Health Probiotics for treating neuropathic bladder associated urinary tract infection
US20210186399A1 (en) * 2019-12-19 2021-06-24 Medtronic, Inc. Urinary tract infection determination
US20210319894A1 (en) * 2020-04-08 2021-10-14 CareBand Inc. Wearable electronic device and system using low-power cellular telecommunication protocols
US20230165728A1 (en) * 2019-10-25 2023-06-01 Driq Health, Inc. Internet of things (iot) solution for management of urinary incontinence

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140276928A1 (en) 2013-03-15 2014-09-18 Medtronic, Inc. Subcutaneous delivery tool
US20160015758A1 (en) * 2014-07-21 2016-01-21 Medstar Health Probiotics for treating neuropathic bladder associated urinary tract infection
US20230165728A1 (en) * 2019-10-25 2023-06-01 Driq Health, Inc. Internet of things (iot) solution for management of urinary incontinence
US20210186399A1 (en) * 2019-12-19 2021-06-24 Medtronic, Inc. Urinary tract infection determination
US20210319894A1 (en) * 2020-04-08 2021-10-14 CareBand Inc. Wearable electronic device and system using low-power cellular telecommunication protocols

Similar Documents

Publication Publication Date Title
US10376159B2 (en) Exercise triggered cardiovascular pressure measurement
US12121332B2 (en) Performing one or more pulse transit time measurements based on an electrogram signal and a photoplethysmography signal
US7616988B2 (en) System and method for detecting an involuntary muscle movement disorder
US11602313B2 (en) Determining a fall risk responsive to detecting body position movements
EP4059425B1 (fr) Détection et/ou prédiction d'une condition médicale à l'aide de la fibrillation auriculaire et de mesures du glucose
US20240156402A1 (en) Determining an efficacy of a treatment program
US20210106253A1 (en) Detecting one or more patient coughs based on an electrogram signal and an accelerometer signal
US12194304B2 (en) Implantable medical device using internal sensors to determine when to switch operational modes
WO2025149807A1 (fr) Système de dispositif médical implantable configuré pour la détermination d'une infection urinaire
US20250268522A1 (en) Closed loop care system based on compliance with a prescribed medication plan
EP4629882A1 (fr) Prédiction ou détection d'événements cardiaques indésirables majeurs par rupture dans une réponse sympathique
US20230364435A1 (en) Implantable medical device using internal sensors to determine when to switch operational modes
US20240041346A1 (en) Cough detection using frontal accelerometer
US20240138743A1 (en) Premature ventricular contraction (pvc) detection using an artificial intelligence model
US20250185975A1 (en) Estimation of serum potassium and/or glomerular filtration rate from electrocardiogram for management of heart failure patients
WO2025224544A1 (fr) Fonctionnement d'un système de dispositif médical pour identifier des échantillons de données cardiaques particuliers associés à un événement cardiaque
WO2025125960A1 (fr) Système destiné à étalonner des valeurs de tension artérielle déduites optiquement à l'aide d'un dispositif médical implantable
WO2025210417A1 (fr) Système médical pour la détermination d'un score de risque pour prédire la survenue d'arythmies et/ou d'arrêt cardiaque soudain
WO2025088408A1 (fr) Fonctionnement d'un système de dispositif médical pour déterminer des positions de fenêtre d'un signal de battement de bruit cardiaque pour extraire des caractéristiques de bruit cardiaque
WO2023203432A2 (fr) Identification de troubles respiratoires pendant le sommeil

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24834851

Country of ref document: EP

Kind code of ref document: A1